Cargando…
Development of a fluorogenic ADAMTS-7 substrate
The extracellular protease ADAMTS-7 has been identified as a potential therapeutic target in atherosclerosis and associated diseases such as coronary artery disease (CAD). However, ADAMTS-7 inhibitors have not been reported so far. Screening of inhibitors has been hindered by the lack of a suitable...
Autores principales: | Santamaria, Salvatore, Buemi, Frederic, Nuti, Elisa, Cuffaro, Doretta, De Vita, Elena, Tuccinardi, Tiziano, Rossello, Armando, Howell, Steven, Mehmood, Shahid, Snijders, Ambrosius P., de Groot, Rens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494430/ https://www.ncbi.nlm.nih.gov/pubmed/34587841 http://dx.doi.org/10.1080/14756366.2021.1983808 |
Ejemplares similares
-
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
por: Santamaria, Salvatore, et al.
Publicado: (2021) -
Targeting Aggrecanases
for Osteoarthritis Therapy:
From Zinc Chelation to Exosite Inhibition
por: Cuffaro, Doretta, et al.
Publicado: (2022) -
Proteomic discovery of substrates of the cardiovascular protease ADAMTS7
por: Colige, Alain, et al.
Publicado: (2019) -
An overview of carbohydrate-based carbonic anhydrase inhibitors
por: Cuffaro, Doretta, et al.
Publicado: (2020) -
ADAMTS proteases in cardiovascular physiology and disease
por: Santamaria, Salvatore, et al.
Publicado: (2020)